Doxercalciferol-D3
| Title | Journal |
|---|---|
| Resveratrol alleviates vascular inflammatory injury by inhibiting inflammasome activation in rats with hypercholesterolemia and vitamin D2 treatment. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20150501 |
| Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient mice. | Therapeutic advances in cardiovascular disease 20141201 |
| In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. | Molecular and cellular endocrinology 20140305 |
| Generation of potentially bioactive ergosterol-derived products following pulsed ultraviolet light exposure of mushrooms (Agaricus bisporus). | Food chemistry 20121115 |
| The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. | The Journal of steroid biochemistry and molecular biology 20121101 |
| Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. | Pharmacoepidemiology and drug safety 20121101 |
| In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. | American journal of physiology. Renal physiology 20121015 |
| Vitamin D receptor activation in a diabetic-like environment: potential role in the activity of the endothelial pro-inflammatory and thioredoxin pathways. | The Journal of steroid biochemistry and molecular biology 20121001 |
| Vitamin D status of children receiving chronic dialysis. | Pediatric nephrology (Berlin, Germany) 20121001 |
| Expression of human CYP27B1 in Escherichia coli and characterization in phospholipid vesicles. | The FEBS journal 20121001 |
| Synthesis and biological evaluation of a new vitamin D2 analogue. | Bioorganic & medicinal chemistry letters 20121001 |
| VDRA therapy is associated with improved survival in dialysis patients with serum intact PTH ≤ 150 pg/mL: results of the Italian FARO Survey. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120901 |
| Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B. | The Journal of clinical endocrinology and metabolism 20120901 |
| Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2. | Oncology reports 20120901 |
| Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model. | Journal of Korean medical science 20120901 |
| Treatment of vitamin D deficiency within a large integrated health care delivery system. | Journal of managed care pharmacy : JMCP 20120901 |
| Exposure-clinical response analysis of paricalcitol in patients with chronic kidney disease (stage 5) on hemodialysis or peritoneal dialysis. | Journal of clinical pharmacology 20120801 |
| Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120801 |
| Long-term management of CKD-mineral and bone disorder. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20120801 |
| Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol − a preliminary study. | Clinical nephrology 20120801 |
| Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model. | The British journal of radiology 20120801 |
| Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease. | Geriatrics & gerontology international 20120701 |
| Ergocalciferol and cholecalciferol in CKD. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20120701 |
| Vitamin D receptor activation and prevention of arterial ageing. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20120701 |
| Role of mitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathy. | American journal of physiology. Renal physiology 20120615 |
| The effect of vitamin D derivatives on vascular calcification associated with inflammation. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120601 |
| Changes in fibroblast growth factor 23 during treatment of secondary hyperparathyroidism with alfacalcidol or paricalcitol. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120601 |
| Treatment of vitamin D insufficiency in children and adolescents with inflammatory bowel disease: a randomized clinical trial comparing three regimens. | The Journal of clinical endocrinology and metabolism 20120601 |
| Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation. | European journal of pharmacology 20120515 |
| Microalbuminuria, another use for paricalcitol? Our experience in advanced chronic kidney disease. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120514 |
| Paricalcitol versus cinacalcet plus low-dose vitamin D for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: study design and baseline characteristics of the IMPACT SHPT study. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120501 |
| Treatment of vitamin D deficiency: divergence between clinical practice and expert advice. | Postgraduate medical journal 20120501 |
| Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers. | Clinical journal of the American Society of Nephrology : CJASN 20120501 |
| [Vitamin D metabolism]. | Vnitrni lekarstvi 20120501 |
| Impact of high-pressure processing on vitamin E (α-, γ-, and δ-tocopherol), vitamin D (cholecalciferol and ergocalciferol), and fatty acid profiles in liquid foods. | Journal of agricultural and food chemistry 20120411 |
| Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23. | Clinical journal of the American Society of Nephrology : CJASN 20120401 |
| Serum 24,25-dihydroxyvitamin D concentrations in osteogenesis imperfecta: relationship to bone parameters. | The Journal of clinical endocrinology and metabolism 20120401 |
| An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. | The Journal of clinical endocrinology and metabolism 20120401 |
| Protective effect of paricalcitol on cyclosporine-induced renal injury in rats. | Transplantation proceedings 20120401 |
| Beyond proteinuria: VDR activation reduces renal inflammation in experimental diabetic nephropathy. | American journal of physiology. Renal physiology 20120315 |
| Human cytochrome P450scc (CYP11A1) catalyzes epoxide formation with ergosterol. | Drug metabolism and disposition: the biological fate of chemicals 20120301 |
| Nutritional vitamin D supplementation in haemodialysis: A potential vascular benefit? | Nephrology (Carlton, Vic.) 20120301 |
| Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis. | Clinical journal of the American Society of Nephrology : CJASN 20120301 |
| Vitamin D supplementation: guidelines and evidence for subclinical deficiency. | Current opinion in gastroenterology 20120301 |
| [Unsuccessful vitamin D treatment]. | Ugeskrift for laeger 20120227 |
| Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. | JAMA 20120215 |
| Vitamin D in chronic kidney disease: more questions than answers. | JAMA 20120215 |
| Calciferol deficiency mimicking abusive fractures in infants: is there any evidence? | The Journal of pediatrics 20120201 |
| The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D₂) or cholecalciferol (D₃) in alcoholic liver cirrhosis. | European journal of gastroenterology & hepatology 20120201 |
| Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. | Clinical journal of the American Society of Nephrology : CJASN 20120201 |
| A randomised clinical study of alfacalcidol and paricalcitol. | Danish medical journal 20120201 |
| Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation. | Pharmacotherapy 20120201 |
| Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20120101 |
| Left ventricular periostin gene expression is associated with fibrogenesis in experimental renal insufficiency. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120101 |
| Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20120101 |
| Effect of paricalcitol and GcMAF on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling. | Journal of nephrology 20120101 |
| Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats. | American journal of physiology. Renal physiology 20120101 |
| Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialysis patients with secondary hyperparathyroidism: 12-month prospective study. | Renal failure 20120101 |
| Characterization of ergocalciferol loaded solid lipid nanoparticles. | Journal of food science 20120101 |
| Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. | BMC infectious diseases 20120101 |
| Role of vitamin d receptor activators in cardio-renal syndromes. | Seminars in nephrology 20120101 |
| Treatment with 50,000 IU vitamin D₂ every other week and effect on serum 25-hydroxyvitamin D₂, 25-hydroxyvitamin D₃, and total 25-hydroxyvitamin D in a clinical setting. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20120101 |
| Paricalcitol for pre-dialysis stages of chronic kidney disease. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20120101 |
| Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. | PloS one 20120101 |
| [Is daily supplementation with vitamin D2 equivalent to daily supplementation with vitamin D3 in the elderly?]. | Medicina 20120101 |
| Determination of vitamins D2 and D3 in infant formula and adult nutritionals by ultra-pressure liquid chromatography with tandem mass spectrometry detection (UPLC-MS/MS): First Action 2011.12. | Journal of AOAC International 20120101 |
| Simultaneous determination of vitamins D2 and D3 by LC-MS/MS in infant formula and adult nutritionals: First Action 2011.13. | Journal of AOAC International 20120101 |
| Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial. | Journal of neurology, neurosurgery, and psychiatry 20111201 |
| Low bone mineral density and nutritional vitamin D deficiency in pediatric renal transplant recipients: Assessment of risk factors and response to oral vitamin D therapy. | Pediatric transplantation 20111201 |
| [Vitamin D supplemention in the elderly]. | Deutsche medizinische Wochenschrift (1946) 20111201 |
| Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats. | Journal of cardiac failure 20111201 |
| ACP Journal Club. Review: cholecalciferol (vitamin D3) reduces mortality in adults; other forms of vitamin D do not. | Annals of internal medicine 20111115 |
| Short-term vitamin D receptor activation increases serum creatinine due to increased production with no effect on the glomerular filtration rate. | Kidney international 20111101 |
| Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines. | Gynecologic oncology 20111101 |
| Short-term effects of vitamin D receptor activation on serum creatinine, creatinine generation, and glomerular filtration. | Kidney international 20111101 |
| Clinical inquiries. Which regimen treats vitamin D deficiency most effectively? | The Journal of family practice 20111101 |
| Seasonal variation of provitamin D2 and vitamin D2 in perennial ryegrass (Lolium perenne L.). | Journal of agricultural and food chemistry 20111026 |
| Vectorized ferrocenes with estrogens and vitamin D2: synthesis, cytotoxic activity and docking studies. | Dalton transactions (Cambridge, England : 2003) 20111007 |
| Evaluation of bone markers in hypophosphatemic rickets/osteomalacia. | Endocrine 20111001 |
| No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial. | Kidney international 20111001 |
| New clinical trials with vitamin D and analogs in renal disease. | Kidney international 20111001 |
| Hypervitaminosis D associated with a vitamin D dispensing error. | The Annals of pharmacotherapy 20111001 |
| Clinical applications for vitamin D assays: what is known and what is wished for. | Clinical chemistry 20110901 |
| VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects. | British journal of pharmacology 20110901 |
| Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. | Cardiovascular research 20110901 |
| Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry. | Clinical chemistry 20110901 |
| The relation between vitamin D deficiency and fibromyalgia syndrome in women. | Saudi medical journal 20110901 |
| [Skeletal and extra-skeletal consequences of vitamin D deficiency]. | Orvosi hetilap 20110814 |
| Bioavailability of vitamin D₂ from UV-B-irradiated button mushrooms in healthy adults deficient in serum 25-hydroxyvitamin D: a randomized controlled trial. | European journal of clinical nutrition 20110801 |
| Structure-function analysis of vitamin D(2) analogs as potential inducers of leukemia differentiation and inhibitors of prostate cancer proliferation. | The Journal of steroid biochemistry and molecular biology 20110801 |
| Bioavailability of vitamin D in malnourished adolescents with anorexia nervosa. | The Journal of clinical endocrinology and metabolism 20110801 |
| Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. | Breast cancer research and treatment 20110801 |
| Determination of vitamins A, D and E in a small volume of human plasma by a high-throughput method based on liquid chromatography/tandem mass spectrometry. | Rapid communications in mass spectrometry : RCM 20110730 |
| Vitamin D and sterol composition of 10 types of mushrooms from retail suppliers in the United States. | Journal of agricultural and food chemistry 20110727 |
| Vitamin D supplementation for prevention of mortality in adults. | The Cochrane database of systematic reviews 20110706 |
| Vitamin D in organ transplantation. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110701 |
| Vitamin D₂ impairs utilization of vitamin D₃ in high-yielding dairy cows in a cross-over supplementation regimen. | Journal of dairy science 20110701 |
| Combination vitamin D therapy in stage 5 chronic kidney disease. | The Annals of pharmacotherapy 20110701 |
| Vitamin D and cancer: uncertainty persists; research continues. | Journal of the National Cancer Institute 20110608 |
| Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. | Cardiovascular drugs and therapy 20110601 |
| Paricalcitol in secondary hyperparathyroidism and the survival benefit in patients with chronic kidney disease. | Journal of renal care 20110601 |
| The role of paricalcitol on proteinuria. | Journal of renal care 20110601 |
| Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism. | Rheumatology international 20110501 |
| High prevalence of undetected vitamin D deficiency in an urban minority primary care practice. | Journal of the National Medical Association 20110501 |
| Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor. | Journal of molecular endocrinology 20110401 |
| Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. | The Journal of clinical endocrinology and metabolism 20110401 |
| Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study. | Scandinavian journal of urology and nephrology 20110401 |
| The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease. | Clinical trials (London, England) 20110401 |
| Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice. | American journal of physiology. Renal physiology 20110301 |
| Vitamin D(3) is more potent than vitamin D(2) in humans. | The Journal of clinical endocrinology and metabolism 20110301 |
| Vitamin D receptor agonist doxercalciferol modulates dietary fat-induced renal disease and renal lipid metabolism. | American journal of physiology. Renal physiology 20110301 |
| Vitamin D: the iceberg nutrient. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20110301 |
| Paricalcitol for reduction of albuminuria in diabetes. | Lancet (London, England) 20110219 |
| Paricalcitol for reduction of albuminuria in diabetes. | Lancet (London, England) 20110219 |
| Paricalcitol for reduction of albuminuria in diabetes. | Lancet (London, England) 20110219 |
| Paricalcitol for reduction of albuminuria in diabetes. | Lancet (London, England) 20110219 |
| Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations. | British journal of pharmacology 20110201 |
| Micronutrients at the interface between inflammation and infection--ascorbic acid and calciferol. Part 2: calciferol and the significance of nutrient supplements. | Inflammation & allergy drug targets 20110201 |
| Micronutrients at the interface between inflammation and infection--ascorbic acid and calciferol: part 1, general overview with a focus on ascorbic acid. | Inflammation & allergy drug targets 20110201 |
| Supplemental vitamin D and calcium in the management of African Americans with heart failure having hypovitaminosis D. | The American journal of the medical sciences 20110201 |
| Determination of 1,25-dihydroxyvitamin D2 in rat serum using liquid chromatography with tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110115 |
| Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. | Journal of nephrology 20110101 |
| Comparative effectiveness of paricalcitol versus cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. | Nephron. Clinical practice 20110101 |
| Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. | Kidney international 20110101 |
| Blockade of Wnt/β-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. | Journal of the American Society of Nephrology : JASN 20110101 |
| Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2 , vitamin D3 , 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. | Journal of separation science 20110101 |
| Vitamin D biology: from the discovery to its significance in chronic kidney disease. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20110101 |
| Calcific uremic arteriolopathy while on cinacalcet. | Journal of postgraduate medicine 20110101 |
| Vitamin D receptor activation and left ventricular hypertrophy in advanced kidney disease. | American journal of nephrology 20110101 |
| Vitamin D and nutritional status are related to bone fractures in alcoholics. | Alcohol and alcoholism (Oxford, Oxfordshire) 20110101 |
| Comparative effectiveness of active oral vitamin D agents in patients on peritoneal dialysis. | Nephrology news & issues 20110101 |
| Application of ultra-performance liquid chromatography/tandem mass spectrometry for the measurement of vitamin D in foods and nutritional supplements. | Journal of AOAC International 20110101 |
| Calcific uremic arteriolopathy treated with cinacalcet, paricalcitol, and autologous growth factors. | Journal of cutaneous medicine and surgery 20110101 |
| [Paricalcitol: an ally against proteinuria in diabetic patients?]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20110101 |
| Validated stability-indicating HPLC method for paricalcitol in pharmaceutical dosage form according to ICH guidelines: application to stability studies. | Journal of AOAC International 20110101 |
| Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality. | Blood purification 20110101 |
| Restoring the physiology of vitamin D receptor activation and the concept of selectivity. | Contributions to nephrology 20110101 |
| The impact of paricalcitol on left ventricular hypertrophy. | Contributions to nephrology 20110101 |
| A randomized controlled trial of vitamin D dosing strategies after acute hip fracture: no advantage of loading doses over daily supplementation. | BMC musculoskeletal disorders 20110101 |
| Integrated genomics of ovarian xenograft tumor progression and chemotherapy response. | BMC cancer 20110101 |
| [The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys]. | Terapevticheskii arkhiv 20110101 |
| Effects of oral paricalcitol on hyperparathyroidism and proteinuria in peritoneal dialysis patients. | Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 20110101 |
| Effectiveness of treatment with oral paricalcitol in patients with pre-dialysis chronic kidney disease. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20110101 |
| Paricalcitol, a synthetic vitamin D analog: a candidate for combination therapy with biological agents in rheumatoid arthritis. | Medical hypotheses 20101201 |
| Increased fetuin-A levels following treatment with a vitamin D analog. | Kidney international 20101201 |
| Stability in the rumen and effect on plasma status of single oral doses of vitamin D and vitamin E in high-yielding dairy cows. | Journal of dairy science 20101201 |
| [Cutaneous calciphylaxis]. | Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 20101201 |
| Circulating 25-hydroxyvitamin D levels and frailty status in older women. | The Journal of clinical endocrinology and metabolism 20101201 |
| An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism--the German perspective. | Surgery 20101201 |
| Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. | Lancet (London, England) 20101106 |
| Into the light? Diabetic nephropathy and vitamin D. | Lancet (London, England) 20101106 |
| Chondro/osteoblastic and cardiovascular gene modulation in human artery smooth muscle cells that calcify in the presence of phosphate and calcitriol or paricalcitol. | Journal of cellular biochemistry 20101101 |
| Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. | American journal of nephrology 20101101 |
| Identification of a unique subset of 2-methylene-19-nor analogs of vitamin D with comedolytic activity in the rhino mouse. | The Journal of investigative dermatology 20101001 |
| Transcriptional activity analysis of promoter region of human PAX9 gene under dexamethasone, retinoic acid, and ergocalciferol treatment in MCF-7 and MDPC23. | Cell biochemistry and function 20101001 |
| Effect of paricalcitol on the urinary peptidome of kidney transplant patients. | Transplantation proceedings 20101001 |
| Comparison of metabolism of vitamins D2 and D3 in children with nutritional rickets. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100901 |
| In vitro culture and differentiation of osteoblasts from human umbilical cord blood. | Cell and tissue banking 20100801 |
| Therapeutic effects of vitamin D analogs on cardiac hypertrophy in spontaneously hypertensive rats. | The American journal of pathology 20100801 |
| Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. | Kidney international. Supplement 20100801 |
| Treatment of secondary hyperparathyroidism in ESRD: a 2-year, single-center crossover study. | Kidney international. Supplement 20100801 |
| Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20100801 |
| Myocardial effects of VDR activators in renal failure. | The Journal of steroid biochemistry and molecular biology 20100701 |
| Failure of alphacalcidol (1alpha-hydroxyvitamin D3) in treating nutritional rickets and the biochemical response to ergocalciferol. | The Journal of steroid biochemistry and molecular biology 20100701 |
| Bladder rupture following osteoporotic pubic ramus and sacral insufficiency fractures. | Age and ageing 20100701 |
| [Studies on the chemical constituents of the flowers of Bupleurum chinese]. | Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20100701 |
| Combined vitamin D analog and AT1 receptor antagonist synergistically block the development of kidney disease in a model of type 2 diabetes. | Kidney international 20100601 |
| Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease. | American journal of physiology. Renal physiology 20100601 |
| Do calcimimetics directly alter bone remodeling? | American journal of physiology. Renal physiology 20100601 |
| Paricalcitol attenuates cyclosporine-induced kidney injury in rats. | Kidney international 20100601 |
| Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects? | Kidney international 20100601 |
| The unsolved cyclosporine-induced kidney injury: is paricalcitol a feasible new renoprotective option? | Kidney international 20100601 |
| Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. | Clinical journal of the American Society of Nephrology : CJASN 20100501 |
| Can vitamin D intake assist in improving the outcome of endodontic treatment for diabetic patients? | Medical hypotheses 20100401 |
| New therapies: calcimimetics, phosphate binders and vitamin D receptor activators. | Pediatric nephrology (Berlin, Germany) 20100401 |
| Use of 3-hour daily hemodialysis and paricalcitol in patients with severe secondary hyperparathyroidism: A case series. | Hemodialysis international. International Symposium on Home Hemodialysis 20100401 |
| Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate? | Clinical nephrology 20100401 |
| Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells. | International urology and nephrology 20100301 |
| Transient effectiveness of vitamin D2 therapy in pediatric cystic fibrosis patients. | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20100301 |
| Monitoring vitamin D concentrations in patients with osteoporosis: a clinical perspective. | Pharmacotherapy 20100301 |
| Vitamin D deficiency: appropriate replenishment therapies and the effects of vitamin D toxicity. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20100301 |
| Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats. | American journal of physiology. Renal physiology 20100201 |
| Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin. | Arteriosclerosis, thrombosis, and vascular biology 20100201 |
| A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. | Clinical journal of the American Society of Nephrology : CJASN 20100201 |
| On call. After reading your article on multivitamins, I've decided to switch from my old multivitamin to plain vitamin D. But I'm confused by various types of vitamin D. Which kind should I take? | Harvard men's health watch 20100201 |
| Pivotal role of paricalcitol in the treatment of calcific uremic arteriolopathy in the presence of a parathyroid adenoma. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20100101 |
| Differential effects of paricalcitol and calcitriol on intestinal calcium absorption in hemodialysis patients. | American journal of nephrology 20100101 |
| Vitamin D for the treatment of chronic painful conditions in adults. | The Cochrane database of systematic reviews 20100101 |
| Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. | Blood purification 20100101 |
| The dual vitamin D pathways: considerations for adequate supplementation. | Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20100101 |
| Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model. | Clinical drug investigation 20100101 |
| Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas. | American journal of nephrology 20100101 |
| Screening for vitamin D deficiency in the elderly. | Journal of the Mississippi State Medical Association 20100101 |
| [Ultrasound parameter-based response to treatment with new drugs for secondary hyperparathyroidism: a retrospective analysis in a single dialysis center]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20100101 |
| [Role of paracalcitol in the management of non-dialysis CKD: state of art and... Unmet needs]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20100101 |
| Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. | Atherosclerosis 20091201 |
| Vitamin D, nervous system and aging. | Psychoneuroendocrinology 20091201 |
| Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy. | Kidney international 20091201 |
| Vitamin D: a new hope for chronic kidney disease? | Kidney international 20091201 |
| [Why and how correct calcidiol deficiency in haemodialysis patients?]. | Nephrologie & therapeutique 20091101 |
| Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. | Bone 20091101 |
| Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20091001 |
| Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. | Clinical immunology (Orlando, Fla.) 20091001 |
| D-hormone derivatives for the treatment of osteoporosis: from alfacalcidol to eldecalcitol. | Mini reviews in medicinal chemistry 20091001 |
| A new look at the most successful prodrugs for active vitamin D (D hormone): alfacalcidol and doxercalciferol. | Molecules (Basel, Switzerland) 20090929 |
| The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone. | American journal of physiology. Renal physiology 20090901 |
| Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. | American journal of physiology. Renal physiology 20090901 |
| The effect of vitamin D2 and vitamin D3 on intestinal calcium absorption in Nigerian children with rickets. | The Journal of clinical endocrinology and metabolism 20090901 |
| Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study. | Clinical endocrinology 20090801 |
| Intravenous calcitriol versus paricalcitol in haemodialysis patients with severe secondary hyperparathyroidism. | Nephrology (Carlton, Vic.) 20090801 |
| Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 20090701 |
| The lack of vitamin D toxicity with megadose of daily ergocalciferol (D2) therapy: a case report and literature review. | Southern medical journal 20090701 |
| Selective monitoring of vitamin D2 and D3 supplementation with a highly specific 25-hydroxyvitamin D3 immunoassay with negligible cross-reactivity to 25-hydroxyvitamin D2. | Clinica chimica acta; international journal of clinical chemistry 20090627 |
| Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. | The Journal of clinical endocrinology and metabolism 20090601 |
| Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. | Multiple sclerosis (Houndmills, Basingstoke, England) 20090601 |
| Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the 'U'. | Clinical nephrology 20090601 |
| Comment on 'In vitro model of vitamin D(3) (cholecalciferol) synthesis by UV radiation: dose-response relationships' by W.J. Olds, A.R. McKinley, M.R. Moore and M.G. Kimlin, J. Photochem. Photobiol. B: Biol. 93 (2008) 88-93. | Journal of photochemistry and photobiology. B, Biology 20090504 |
| Chronic kidney disease Markov model comparing paricalcitol to calcitriol for secondary hyperparathyroidism: a US perspective. | Current medical research and opinion 20090501 |
| Vitamin D2 formation and bioavailability from Agaricus bisporus button mushrooms treated with ultraviolet irradiation. | Journal of agricultural and food chemistry 20090422 |
| Effect of free vitamin D(2) drops on serum 25-hydroxyvitamin D in infants with immigrant origin: a cluster randomized controlled trial. | European journal of clinical nutrition 20090401 |
| Metabolism of vitamin d2 to 17,20,24-trihydroxyvitamin d2 by cytochrome p450scc (CYP11A1). | Drug metabolism and disposition: the biological fate of chemicals 20090401 |
| Battle against the renin-angiotensin system: help from an unexpected party. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20090401 |
| I've heard that some supplements contain vitamin D2 while others contain vitamin D3. Is one more effective? | Mayo Clinic women's healthsource 20090401 |
| The effect of paricalcitol on osteoprotegerin production by human peripheral blood mononuclear cells. | The Journal of rheumatology 20090401 |
| A single high dose of ergocalciferol can be used to boost 25-hydroxyvitamin D levels in children with kidney disease. | Pediatric nephrology (Berlin, Germany) 20090301 |
| Dietary calcium and vitamin D2 supplementation with enhanced Lentinula edodes improves osteoporosis-like symptoms and induces duodenal and renal active calcium transport gene expression in mice. | European journal of nutrition 20090301 |
| Role of vitamin D in chronic kidney disease. | Seminars in nephrology 20090301 |
| High-cholesterol + vitamin D2 regimen: a questionable in-vivo experimental model of aortic valve stenosis. | The Journal of heart valve disease 20090301 |
| Paricalcitol and renin-angiotensin components in remnant kidneys. | Kidney international 20090201 |
| . . . About osteoporosis. | Nursing 20090201 |
| Vitamin D receptor activators. | The International journal of artificial organs 20090201 |
| Case records of the Massachusetts General Hospital. Case 3-2009. A 9-month-old boy with seizures. | The New England journal of medicine 20090122 |
| Identification of tissue factor in experimental aortic valve sclerosis. | Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 20090101 |
| Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations. | American journal of nephrology 20090101 |
| A study on vitamin D and vitamin A in milk and edible oils available in the United Arab Emirates. | International journal of food sciences and nutrition 20090101 |
| The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. | Scandinavian journal of rheumatology 20090101 |
| Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats. | American journal of nephrology 20090101 |
| Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients on sevelamer hydrochloride: which dialysate calcium concentration to use? | Blood purification 20090101 |
| Significant vitamin D deficiency in youth with type 1 diabetes mellitus. | The Journal of pediatrics 20090101 |
| Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients. | Journal of nephrology 20090101 |
| Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090101 |
| Simultaneous determination of cholecalciferol (vitamin D3) and ergocalciferol (vitamin D2) in foods by selected reaction monitoring. | Journal of AOAC International 20090101 |
| Osteomalacia with bone marrow fibrosis due to severe vitamin D deficiency after a gastrointestinal bypass operation for severe obesity. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20090101 |
| Importance of vitamin D receptor activation in clinical practice. | Contributions to nephrology 20090101 |
| New acquisitions in therapy of secondary hyperparathyroidism in chronic kidney disease and peritoneal dialysis patients: role of vitamin D receptor activators. | Contributions to nephrology 20090101 |
| The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics. | American journal of nephrology 20090101 |
| [Multiple peritrochanteric and pubic calcifications in a young woman on hemodialysis with severe renal osteodystrophy successfully treated with sevelamer+cinacalcet+paracalcitol combination therapy]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20090101 |
| Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol. | BMC nephrology 20090101 |
| Measurement of vitamin D in foods and nutritional supplements by liquid chromatography/tandem mass spectrometry. | Journal of AOAC International 20090101 |
| A cavitand with a fluorous rim acts as an amine receptor. | Chemical communications (Cambridge, England) 20081221 |
| Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20081201 |
| Vitamin D2, vitamin D3, and the tolerable upper intake level. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081201 |
| Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. | Kidney international 20081201 |
| Rapid correction of low vitamin D status in nursing home residents. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20081101 |
| Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. | Clinical journal of the American Society of Nephrology : CJASN 20081101 |
| Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. | Cancer chemotherapy and pharmacology 20081001 |
| [Vitamin D2 or vitamin D3?]. | La Revue de medecine interne 20081001 |
| Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate. | The Journal of pediatrics 20081001 |
| VDRAs versus calcimimetics: better safe than sorry? | Kidney international 20081001 |
| Vitamin D receptor ligand therapy in chronic kidney disease. | Clinical nephrology 20081001 |
| Converting hemodialysis patients from intravenous paricalcitol to intravenous doxercalciferol - a dose equivalency and titration study. | Clinical nephrology 20081001 |
| Vitamin D: a rapid review. | Urologic nursing 20081001 |
| Vitamin D2 potentiates axon regeneration. | Journal of neurotrauma 20081001 |
| An adolescent boy with thalassemia major presenting with bone pain, numbness, tetanic contractions and growth and pubertal delay: panhypopituitarism and combined vitamin D and parathyroid defects. | Pediatric endocrinology reviews : PER 20081001 |
| Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. | Journal of the American Society of Nephrology : JASN 20080901 |
| Vitamin D in health and disease. | Clinical journal of the American Society of Nephrology : CJASN 20080901 |
| Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein. | European journal of pharmacology 20080820 |
| Vitamin D receptor activators can protect against vascular calcification. | Journal of the American Society of Nephrology : JASN 20080801 |
| Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. | The Journal of clinical endocrinology and metabolism 20080801 |
| Is activated vitamin D supplementation renoprotective? | Hypertension (Dallas, Tex. : 1979) 20080801 |
| Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. | Hypertension (Dallas, Tex. : 1979) 20080801 |
| Combination of sodium thiosulphate, cinacalcet, and paricalcitol in the treatment of calciphylaxis with hyperparathyroidism. | The International journal of artificial organs 20080801 |
| 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism. | Journal of endocrinological investigation 20080801 |
| Nutritional rickets and z scores for height in the United Arab Emirates: to D or not to D? | Pediatrics international : official journal of the Japan Pediatric Society 20080801 |
| Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20080701 |
| Perspectives on vitamin D therapy in chronic kidney disease. | Nephrology news & issues 20080701 |
| Development of aortic valve sclerosis or stenosis in rabbits: role of cholesterol and calcium. | The Journal of heart valve disease 20080701 |
| Risedronic acid and calcium + colecalciferol: new combination. A simple combination of two other products. A simple commercial ploy with no benefit for patients. | Prescrire international 20080601 |
| Induction of apoptosis by vitamin D2, ergocalciferol, via reactive oxygen species generation, glutathione depletion, and caspase activation in human leukemia Cells. | Journal of agricultural and food chemistry 20080514 |
| Stridor secondary to hypocalcemia in the elderly: an unusual presentation. | European journal of internal medicine 20080501 |
| [Vitamin D supplementation to breast feeding mothers not dangerous for the child]. | Lakartidningen 20080501 |
| Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080415 |
| Sickle cell bone disease: response to vitamin D and calcium. | American journal of hematology 20080401 |
| Ectopic thymic parathyroid adenoma and vitamin D deficiency rickets: a 5-year-follow-up case report and review of literature. | Bone 20080401 |
| Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism. | Expert opinion on pharmacotherapy 20080401 |
| Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol. | Current vascular pharmacology 20080401 |
| Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. | The Journal of clinical endocrinology and metabolism 20080301 |
| 19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo. | Cancer biology & therapy 20080301 |
| Calcium balance during calcitriol and paricalcitol administration in healthy humans. | International journal of clinical pharmacology and therapeutics 20080301 |
| The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats. | Kidney international 20080201 |
| Vitamin D supplementation to prevent falls in the elderly: evidence and practical considerations. | Pharmacotherapy 20080201 |
| 'No child need have rickets' revisited. | Journal of pediatric endocrinology & metabolism : JPEM 20080201 |
| Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. | Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20080201 |
| Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. | Archives of internal medicine 20080114 |
| Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. | American journal of nephrology 20080101 |
| Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome. | Leukemia & lymphoma 20080101 |
| Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080101 |
| The value of vitamin D(3) over vitamin D(2) in older persons. | Geriatric nursing (New York, N.Y.) 20080101 |
| Improved patient outcomes in chronic kidney disease: optimizing vitamin D therapy. | Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20080101 |
| Antiproliferative effect of vitamin A and D analogues on adult human keratinocytes in vitro. | Skin pharmacology and physiology 20080101 |
| Paricalcitol treatment and arterial tone in experimental renal insufficiency. | Nephron. Experimental nephrology 20080101 |
| Effect of vitamin D supplementation on calcidiol and parathyroid hormone levels. | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20080101 |
| [Clinical advances in vascular calcification]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101 |
| 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. | Journal of neuro-oncology 20071201 |
| Protective effect of lysozyme chloride on gastric oxidative stress and hemorrhagic ulcers in severe atherosclerotic rats. | Medical science monitor : international medical journal of experimental and clinical research 20071201 |
| Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. | American journal of physiology. Renal physiology 20071101 |
| Whole or fragmentary information on parathyroid hormone? | Clinical journal of the American Society of Nephrology : CJASN 20071101 |
| Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease. | Clinical journal of the American Society of Nephrology : CJASN 20071101 |
| Relationship between vitamin D and muscle size and strength in patients on hemodialysis. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20071101 |
| Detection and quantification of provitamin D2 and vitamin D2 in hop (Humulus lupulus L.) by liquid chromatography-diode array detection-electrospray ionization tandem mass spectrometry. | Journal of agricultural and food chemistry 20071003 |
| Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol. | Kidney international 20071001 |
| The effects of vitamin D deficiency and insufficiency on the endocrine and paracrine systems. | Biological research for nursing 20071001 |
| Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. | Kidney international 20070901 |
| Vascular calcification in chronic kidney disease: new developments in drug therapy. | Kidney international 20070901 |
| [Treatment of hypoparathyroidism by active vitamin D]. | Clinical calcium 20070801 |
| The brain-heart connection. | Circulation 20070703 |
| Mechanisms of transcriptional repression by 1,25(OH)2 vitamin D. | Current opinion in nephrology and hypertension 20070701 |
| Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20070701 |
| [Vitamine D in patients with osteoporosis: sufficient or necessary?]. | Revue medicale suisse 20070613 |
| Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. | Vascular pharmacology 20070601 |
| Differential effects of vitamin D analogs on vascular calcification. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070601 |
| Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070601 |
| Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. | Journal of the American Society of Nephrology : JASN 20070601 |
| Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20070601 |
| Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. | Journal of managed care pharmacy : JMCP 20070601 |
| [New Active vitamin D analogs and calcimimetics to control hyperparathyroidism in chronic renal failure]. | Clinical calcium 20070501 |
| VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells. | Journal of cellular biochemistry 20070415 |
| Optimal paricalcitol starting dose for parathyroid hormone suppression in secondary hyperparathyroidism. | Nature clinical practice. Nephrology 20070401 |
| Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol. | Nature clinical practice. Nephrology 20070401 |
| Survival differences between activated injectable vitamin D2 and D3 analogs. | Kidney international 20070401 |
| Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. | Neurology 20070320 |
| Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects. | Biopharmaceutics & drug disposition 20070301 |
| The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. | The Journal of steroid biochemistry and molecular biology 20070301 |
| Vascular calcification in chronic kidney failure: role of vitamin D receptor. | Current opinion in investigational drugs (London, England : 2000) 20070301 |
| Determinants of vitamin D levels in nursing home residents. | Journal of the American Medical Directors Association 20070201 |
| Less-calcemic vitamin D analogs enhance creatine kinase specific activity and modulate responsiveness to gonadal steroids in rat skeletal tissues. | Journal of endocrinological investigation 20070201 |
| Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells. | Journal of vascular research 20070101 |
| Impact of kidney bone disease and its management on survival of patients on dialysis. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20070101 |
| Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. | American journal of nephrology 20070101 |
| Comparative cost-benefit analyses of paricalcitol and calcitriol in stage 4 chronic kidney disease from the perspective of a health plan. | Clinical drug investigation 20070101 |
| Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. | Nephron. Clinical practice 20070101 |
| Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs. | Journal of nephrology 20070101 |
| Long-term outcomes of cinacalcet and paricalcitol titration protocol for treatment of secondary hyperparathyroidism. | American journal of nephrology 20070101 |
| Managing bone parameters in dialysis patients: international guideline conflicts. | Seminars in dialysis 20070101 |
| Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. | Nephron. Physiology 20070101 |
| Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. | Drugs 20070101 |
| Nonclassical aspects of differential vitamin D receptor activation: implications for survival in patients with chronic kidney disease. | Drugs 20070101 |
| Convenient analysis of vitamin D in cheese and other food matrixes by liquid chromatography/mass spectrometry. | Journal of AOAC International 20070101 |
| Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis. | Clinical drug investigation 20070101 |
| The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics. | Oncology research 20070101 |
| Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. | Journal of the American Society of Nephrology : JASN 20061201 |
| Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols. | Calcified tissue international 20061201 |
| Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease. | Nephrology (Carlton, Vic.) 20061201 |
| Vitamin D2 from irradiated mushrooms significantly increases femur bone mineral density in rats. | Journal of toxicology and environmental health. Part A 20061101 |
| Cholecalciferol, not ergocalciferol, should be used for vitamin D supplementation. | Age and ageing 20061101 |
| Mortality risk among hemodialysis patients receiving different vitamin D analogs. | Kidney international 20061101 |
| Doxercalciferol treatment of secondary hyperparathyroidism. | The Annals of pharmacotherapy 20061101 |
| Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients. | Pediatric nephrology (Berlin, Germany) 20061001 |
| Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. | Age and ageing 20060901 |
| Parathyromatosis and the challenge of treatment. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20060901 |
| Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. | Kidney international 20060801 |
| Risk of vitamin A toxicity from candy-like chewable vitamin supplements for children. | Pediatrics 20060801 |
| Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. | Movement disorders : official journal of the Movement Disorder Society 20060701 |
| Regio and stereoselective oxidations of unsaturated steroidal compounds with H2O2 mediated by CH3ReO3. | Steroids 20060701 |
| Initial dosing of paricalcitol based on PTH levels in hemodialysis patients with secondary hyperparathyroidism. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20060701 |
| An alternative pathway of vitamin D metabolism. Cytochrome P450scc (CYP11A1)-mediated conversion to 20-hydroxyvitamin D2 and 17,20-dihydroxyvitamin D2. | The FEBS journal 20060701 |
| Does paricalcitol reduce proteinuria in patients with chronic kidney disease? | Nature clinical practice. Nephrology 20060701 |
| Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20060601 |
| Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. | Atherosclerosis 20060501 |
| Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. | European journal of clinical nutrition 20060501 |
| Differential effects of very high doses of doxercalciferol and paricalcitol on serum phosphorus in hemodialysis patients. | Clinical nephrology 20060501 |
| Paricalcitol [19-nor-1,25-(OH)2D2] in the treatment of experimental renal bone disease. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060501 |
| Paricalcitol capsules for the control of secondary hyperparathyroidism in chronic kidney disease. | Expert opinion on pharmacotherapy 20060401 |
| Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells. | Leukemia & lymphoma 20060401 |
| Vitamin D and acute promyelocytic leukemia. | Leukemia & lymphoma 20060401 |
| The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060301 |
| Cardiovascular disease in chronic kidney failure: the role of VDR activators. | Current opinion in investigational drugs (London, England : 2000) 20060301 |
| Severe hypercalcemia after transition from calcium carbonate to calcium citrate in an elderly woman treated with ergocalciferol 50,000 IU per day. | The American journal of geriatric pharmacotherapy 20060301 |
| Cinacalcet hydrochloride (Sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. | Clinical journal of the American Society of Nephrology : CJASN 20060301 |
| Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20060201 |
| Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2. | Biochimica et biophysica acta 20060201 |
| Differential effects of Vitamin D analogs on bone formation and resorption. | The Journal of steroid biochemistry and molecular biology 20060101 |
| Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells. | Thrombosis research 20060101 |
| [Drug-induced hypercalcemia]. | Clinical calcium 20060101 |
| The effect of hepatic insufficiency on the safety and pharmacokinetics of paricalcitol (Zemplar). | Nephron. Clinical practice 20060101 |
| A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4. | American journal of nephrology 20060101 |
| [Inappropriate commercial presentation of selected drugs and associated overcost]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20060101 |
| Therapy of secondary hyperparathyroidism to date: vitamin D analogs, calcimimetics or both? | Journal of nephrology 20060101 |
| Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis. | Clinical drug investigation 20060101 |
| Vitamin D--the iceberg nutrient. | Journal of musculoskeletal & neuronal interactions 20060101 |
| Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells. | Oncology 20060101 |
| Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051215 |
| Antiproteinuric effect of oral paricalcitol in chronic kidney disease. | Kidney international 20051201 |
| Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome. | Leukemia research 20051101 |
| Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. | Journal of the American Geriatrics Society 20051101 |
| [Determination of vitamins D2, vitamin D3 in cosmetics by high performance liquid chromatography]. | Wei sheng yan jiu = Journal of hygiene research 20050901 |
| Fit for a fracture. | The Medical journal of Australia 20050815 |
| Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. | Journal of the American Society of Nephrology : JASN 20050801 |
| The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. | Archives of internal medicine 20050801 |
| Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. | American journal of respiratory and critical care medicine 20050715 |
| Bioavailability of vitamin D from fortified process cheese and effects on vitamin D status in the elderly. | Journal of dairy science 20050701 |
| Vitamin D analogs down-regulate plasminogen activator inhibitor-1 in human coronary artery smooth muscle cells. | Journal of thrombosis and haemostasis : JTH 20050701 |
| Once-weekly intravenous paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients. | Clinical nephrology 20050601 |
| Bioavailability of vitamin D2 from irradiated mushrooms: an in vivo study. | The British journal of nutrition 20050601 |
| Therapeutic approach in a case of Pearson's syndrome. | Minerva pediatrica 20050601 |
| Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. | JAMA 20050511 |
| Activated injectable vitamin D and hemodialysis survival: a historical cohort study. | Journal of the American Society of Nephrology : JASN 20050401 |
| 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia. | Cancer research 20050315 |
| Are new vitamin D analogues in renal bone disease superior to calcitriol? | Pediatric nephrology (Berlin, Germany) 20050301 |
| Cardiovascular disease in chronic kidney failure: is there a role for vitamin D analogs? | Current opinion in investigational drugs (London, England : 2000) 20050301 |
| Myocardial calcification caused by secondary hyperparathyroidism due to dietary deficiency of calcium and vitamin D. | Pediatric cardiology 20050101 |
| Paricalcitol: a review of its use in the management of secondary hyperparathyroidism. | Drugs 20050101 |
| 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors. | Anticancer research 20050101 |
| Spotlight on paricalcitol in secondary hyperparathyroidism. | Treatments in endocrinology 20050101 |
| Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20050101 |
| [New therapeutic strategies in secondary hyperparathyroidism on dialysis (II): vitamin D analogues and calcium-mimetics]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20050101 |
| Pamidronate and 1,24(S)-dihydroxyvitamin D2 synergistically inhibit the growth of myeloma, breast and prostate cancer cells. | Anticancer research 20050101 |
| Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferol. | American journal of nephrology 20050101 |
| Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug. | Anticancer research 20050101 |
| Effect of a vitamin D analog on leg bone mineral density in patients with chronic spinal cord injury. | Journal of rehabilitation research and development 20050101 |
| Production of plasminogen activator inhibitor-1 (PAI-1) by endothelial cells: differential responses to calcitriol and paricalcitol. | Journal of thrombosis and haemostasis : JTH 20041201 |
| Hammers and nails: a report. | Palliative medicine 20041201 |
| Vitamin D2 is much less effective than vitamin D3 in humans. | The Journal of clinical endocrinology and metabolism 20041101 |
| Industry probe. Justice Department subpoenas dialysis providers. | Modern healthcare 20041101 |
| Ergocalciferol promotes in vivo differentiation of keratinocytes and reduces photodamage caused by ultraviolet irradiation in hairless mice. | Photodermatology, photoimmunology & photomedicine 20041001 |
| Accelerated mammary gland development during pregnancy and delayed postlactational involution in vitamin D3 receptor null mice. | Molecular endocrinology (Baltimore, Md.) 20040901 |
| Effects of vitamin D compounds on renal and intestinal Ca2+ transport proteins in 25-hydroxyvitamin D3-1alpha-hydroxylase knockout mice. | Kidney international 20040901 |
| 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats. | Bone 20040901 |
| Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. | Archives of ophthalmology (Chicago, Ill. : 1960) 20040901 |
| Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. | Archives of ophthalmology (Chicago, Ill. : 1960) 20040901 |
| Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. | The British journal of dermatology 20040701 |
| Osteomalacia: recovery of bone density. | The New Zealand medical journal 20040618 |
| Hypovitaminosis D in acutely injured pediatric burn patients. | Journal of the American Dietetic Association 20040601 |
| Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040501 |
| Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20040501 |
| [The trend in the development of the active vitamin D3 and its analogues]. | Nihon rinsho. Japanese journal of clinical medicine 20040501 |
| 19-Nor-1alpha,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations. | The Journal of steroid biochemistry and molecular biology 20040501 |
| [Vitamin D deficiency/insufficiency in patients with chronic kidney disease stage 3 and 4 -- current concept and its therapeutic strategy]. | Clinical calcium 20040501 |
| [Vitamin D supplementation for chronic kidney disease according to the guideline issued by DOQI]. | Clinical calcium 20040501 |
| Invited review: beta-lactoglobulin: binding properties, structure, and function. | Journal of dairy science 20040401 |
| Effect of vitamin D2- and D3-enriched diets on egg vitamin D content, production, and bird condition during an entire production period. | Poultry science 20040301 |
| Vitamin D analogs as therapeutic agents: a clinical study update. | Current opinion in investigational drugs (London, England : 2000) 20040301 |
| Effect of vitamins D2 and D3 supplement use on serum 25OHD concentration in elderly women in summer and winter. | Calcified tissue international 20040201 |
| Hyperparathyroid hypercalcemic crisis in a patient on calcium and vitamin D supplementation. | Clinical nephrology 20040201 |
| Calcimimetics versus vitamin D: what are their relative roles? | Blood purification 20040101 |
| Combination study of 1,24(S)-dihydroxyvitamin D2 and chemotherapeutic agents on human breast and prostate cancer cell lines. | Anticancer research 20040101 |
| Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. | The New England journal of medicine 20031113 |
| Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. | The New England journal of medicine 20031113 |
| Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis. | The New England journal of medicine 20031113 |
| Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20030915 |
| 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells. | British journal of cancer 20030818 |
| Vitamin D metabolism in a frugivorous nocturnal mammal, the Egyptian fruit bat (Rousettus aegyptiacus). | General and comparative endocrinology 20030801 |
| Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. | The New England journal of medicine 20030731 |
| Paricalcitol as compared with calcitriol in patients undergoing hemodialysis. | The New England journal of medicine 20030731 |
| Prevention and treatment of secondary hyperparathyroidism: still a challenge for the nephrologist? | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030701 |
| Selective inhibition of mammalian DNA polymerase alpha by vitamin D2 and D3. | Journal of pharmacological sciences 20030701 |
| Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells. | Journal of the National Cancer Institute 20030618 |
| Efficacy of 19-Nor-1,25-(OH)2D2 in the prevention and treatment of hyperparathyroid bone disease in experimental uremia. | Kidney international 20030601 |
| A strategy for the treatment of calcific uremic arteriolopathy (calciphylaxis) employing a combination of therapies. | Clinical nephrology 20030601 |
| Effect of doxercalciferol (1alpha-hydroxyvitamin D2) on PTH, bone turnover and bone mineral density in a hemodialysis patient with persistent secondary hyperparathyroidism post parathyroidectomy. | Clinical nephrology 20030601 |
| Long-term therapy with paricalcitol for secondary hyperparathyroidism in hemodialysis patients. | The International journal of artificial organs 20030601 |
| Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2. | The Prostate 20030515 |
| A review of intravenous versus oral vitamin D hormone therapy in hemodialysis patients. | Clinical nephrology 20030501 |
| Experimental aortic valve stenosis in rabbits. | Journal of the American College of Cardiology 20030402 |
| Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism. | Kidney international 20030401 |
| Pharmacokinetics of doxercalciferol, a new vitamin D analogue that lowers parathyroid hormone. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030401 |
| The renal dietitian's role in managing hyperphosphatemia and secondary hyperparathyroidism in dialysis patients: a national survey. | Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 20030401 |
| Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. | Ophthalmology 20030401 |
| Competitive effect of vitamin D2 and Ca2+ on phospholipid model membranes: an FTIR study. | Chemistry and physics of lipids 20030401 |
| Synthesis of C-19-functionalized 1alpha-hydroxyvitamin D(2) analogues via ring-closing metathesis. | Organic letters 20030306 |
| [Preparation of complex chitosan microcapsule and its application in controlled release of vitamin D2]. | Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20030301 |
| Rat cytochrome P450C24 (CYP24) does not metabolize 1,25-dihydroxyvitamin D2 to calcitroic acid. | Journal of cellular biochemistry 20030201 |
| 19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines. | Journal of cancer research and clinical oncology 20030101 |
| [Differential effect of vitamin D analogues on the proliferation of vascular smooth muscle cells]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20030101 |
| [Mechanism of uremic osteodystrophy and prevention of hyperparathyroidism in the uremic patient]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20030101 |
| Effects of 'non-calcaemic' vitamin D analogues on 24-hydroxylase expression in MG-63 osteoblast-like cells. | Nephron. Physiology 20030101 |
| [Effect of natural enterosorbents in experimental liver disorders]. | Eksperimental'naia i klinicheskaia farmakologiia 20030101 |
| [Ergocalciferol Reference Standard (Control 031) of National Institute of Health Sciences]. | Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences 20030101 |
| Severe hyperparathyroidism despite paricalcitol therapy: one-year follow-up. | Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 20030101 |
| Preparation of chitosan/ethylcellulose complex microcapsule and its application in controlled release of vitamin D2. | Biomaterials 20021201 |
| Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20021201 |
| First place winner. Recurrent febrile seizures: an unusual presentation of nutritional rickets. | The Journal of emergency medicine 20021101 |
| Differential effects of 19-nor-1,25-(OH)(2)D(2) and 1alpha-hydroxyvitamin D(2) on calcium and phosphorus in normal and uremic rats. | Kidney international 20021001 |
| Low rate of compliance with ergocalciferol therapy in vitamin-D-deficient patients with hip fracture. | The Medical journal of Australia 20020902 |
| Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer. | Clinical cancer research : an official journal of the American Association for Cancer Research 20020901 |
| Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture. | Ophthalmic genetics 20020901 |
| Distal calcific uremic arteriolopathy in a hemodialysis patient responds to lowering of Ca x P product and aggressive wound care. | Clinical nephrology 20020901 |
| Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D(2). (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congeners. | Steroids 20020801 |
| Oral doxercalciferol therapy for secondary hyperparathyroidism in a peritoneal dialysis patient. | Clinical nephrology 20020801 |
| Cats discriminate between cholecalciferol and ergocalciferol. | Journal of animal physiology and animal nutrition 20020801 |
| Use of vitamin D(4) analogs to investigate differences in hepatic and target cell metabolism of vitamins D(2) and D(3). | Biochimica et biophysica acta 20020711 |
| Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. | Archives of ophthalmology (Chicago, Ill. : 1960) 20020501 |
| Differential effects of 19-nor-1,25-dihydroxyvitamin D(2) and 1,25-dihydroxyvitamin D(3) on intestinal calcium and phosphate transport. | The Journal of laboratory and clinical medicine 20020501 |
| Vitamin D deficiency and multicultural Australia. | The Medical journal of Australia 20020304 |
| Pathological long-bone fractures in residents with cerebral palsy in a long-term care facility in South Africa. | Developmental medicine and child neurology 20020201 |
| Vitamin D analogs for the treatment of secondary hyperparathyroidism. | Blood purification 20020101 |
| Comparative review of the pharmacokinetics of vitamin D analogues. | Seminars in dialysis 20020101 |
| Vitamin D analogues for secondary hyperparathyroidism. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20020101 |
| Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice. | Transactions of the American Ophthalmological Society 20020101 |
| Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. | Cell cycle (Georgetown, Tex.) 20020101 |
| Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3. | Molecular pharmacology 20011201 |
| Strategies to minimize bone disease in renal failure. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20011201 |
| p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. | Kidney international 20011201 |
| Severe secondary hyperparathyroidism. | Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20011201 |
| Vitamin D analogues for the management of secondary hyperparathyroidism. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20011101 |
| Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20011101 |
| Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20011101 |
| Paricalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind, multicenter, randomized study. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20011101 |
| [Hypovitaminosis D: a veiled diagnosis]. | Nederlands tijdschrift voor geneeskunde 20011027 |
| A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20011001 |
| A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease. | Clinical nephrology 20011001 |
| Provitamins and vitamins D₂and D₃in Cladina spp. over a latitudinal gradient: possible correlation with UV levels. | Journal of photochemistry and photobiology. B, Biology 20010901 |
| Calcitroic acid is a major catabolic metabolite in the metabolism of 1 alpha-dihydroxyvitamin D(2). | Archives of biochemistry and biophysics 20010801 |
| Double bond in the side chain of 1alpha,25-dihydroxy-22-ene-vitamin D(3) is reduced during its metabolism: studies in chronic myeloid leukemia (RWLeu-4) cells and rat kidney. | The Journal of steroid biochemistry and molecular biology 20010801 |
| Relative potencies of 1,25-(OH)(2)D(3) and 19-Nor-1,25-(OH)(2)D(2) on inducing differentiation and markers of bone formation in MG-63 cells. | Journal of the American Society of Nephrology : JASN 20010701 |
| 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010401 |
| Effect of 1alpha,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3 on metalloproteinase activity and cell maturation in growth plate cartilage in vivo. | Endocrine 20010401 |
| In vitro metabolism of 19-nor-1alpha, 25-(OH)2D2 in cultured cell lines: inducible synthesis of lipid- and water-soluble metabolites. | Archives of biochemistry and biophysics 20010315 |
| Metabolic and endocrine effects of metabolic acidosis in humans. | Swiss medical weekly 20010310 |
| Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparison. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20010301 |
| [The stereocontrolled synthesis of 1-acetylenyl-3-tert-butyldiphenylsilyloxy-exo-bicyclo [3. 1. 0] hexane]. | Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao 20010301 |
| [Advantages of active vitamin D metabolites in the treatment of osteoporosis as compared with calciferol]. | Vnitrni lekarstvi 20010201 |
| The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. | Steroids 20010101 |
| Effects of vitamins on hepatic nuclear binding of L-tryptophan. | Amino acids 20010101 |
| New vitamin D analogs. | Seminars in dialysis 20010101 |
| Vitamin d deficiency in breast-fed toddlers. | Journal of pediatric orthopedics 20010101 |
| [Ergocalciferol Reference Standard (Control 001) of National Institute of Health Sciences]. | Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences 20010101 |
| Comparison of the relative effects of 1,24-dihydroxyvitamin D(2) [1, 24-(OH)(2)D(2)], 1,24-dihydroxyvitamin D(3) [1,24-(OH)(2)D(3)], and 1,25-dihydroxyvitamin D(3) [1,25-(OH)(2)D(3)] on selected vitamin D-regulated events in the rat. | Biochemical pharmacology 20000901 |
| Calcitriol directly sensitizes renal tubular cells to ATP-depletion- and iron-mediated attack. | The American journal of pathology 19990601 |
| Comparative effects of vitamin K2 and vitamin E on experimental arteriosclerosis. | International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 19990101 |
| X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia. | Bone 19971201 |
| Progressively increased serum 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2 intoxication. | Endocrine journal 19940801 |
| Vitamin D2-induced hypercalcemia in rat lens. | Investigative ophthalmology & visual science 19860301 |
| Vitamin D2-induced arteriosclerosis in spontaneously hypertensive rats and protection by diltiazem, a calcium antagonist. | Nihon juigaku zasshi. The Japanese journal of veterinary science 19840601 |
| Reversal of vitamin-D2-induced hypercalciuria by chlorothiazide. | Pediatric research 19830201 |
| Prevention of osteonecrosis following renal transplantation by using vitamin D2 (ergocalciferol). | Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 19830101 |
| Vitamin D3 toxicity in dairy cows. | Journal of dairy science 19820501 |
| Pharmacology and therapeutic use of vitamin D and its analogues. | Drugs 19810401 |
| Inhibition of vitamin D2-induced arteriosclerosis in rats by depletion of complement with cobra venom factor. | Artery 19800101 |
| Does somatostatin in each organ act specifically on that particular organ? | The Tohoku journal of experimental medicine 19790901 |
| Myopathy associated with anticonvulsant osteomalacia. | British medical journal 19731201 |
| A comparison of the toxicity of ergocalciferol and cholecalciferol in rhesus monkeys (Macaca mulatta). | The Journal of nutrition 19720801 |
| Chlorothiazide-induced hypercalcemia in juvenile osteoporosis and hyperparathyroidism. | The New England journal of medicine 19690710 |
| The effect of cortisone on vitamin D2-induced nephrocalcinosis in the rat. | Clinical science 19570201 |